Inclusion Bodies Be Gone

Scientists routinely express heterologous proteins in Escherichia coli. However, these proteins may not fold properly in the bacteria, causing them to aggregate and form insoluble inclusion bodies. Scientists traditionally denature these inclusion bodies with either 8 M urea or 6 M guanidine hydrochloride to solubilize them. These proteins must then be renatured by replacing the denaturants with a gentler buffer. Unfortunately, this process is highly empirical and laborious, and it often results

Written byAmy Constantine
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Researchers at Novagen employed a solubility model developed by D.L. Wilkinson and R.G. Harrison to identify E. coli proteins likely to confer the highest solubility on a fusion partner.1 They then narrowed the range of choices based on size and published data, to end up with three candidate proteins: NusA, bacterioferritin (BFR), and GrpE. Western blot and SDS-PAGE analyses revealed that NusA fusion proteins were more soluble than were fusions with either BFR or GrpE, or with thioredoxin (TRX) and glutathione-S-transferase (GST), two proteins traditionally used to increase solubility of target proteins. A 54-kDa tyrosinase was efficiently expressed as a NusA fusion, suggesting that the Nus·Tag may be a good carrier for large, insoluble proteins.

According to Mark Lepinske, marketing communications manager at Novagen, "The primary feature of the new Novagen Nus·Tag System is the tremendous solubility this new tag tends to confer on a target protein. I don't know ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas

Sino Biological Logo

Sino Biological's Launch of SwiftFluo® TR-FRET Kits Pioneers a New Era in High-Throughout Kinase Inhibitor Screening

SPT Labtech Logo

SPT Labtech enables automated Twist Bioscience NGS library preparation workflows on SPT's firefly platform